IP Library Granted Patent US 7,083,568
Granted Patent B2
US 7,083,568 · App. 10/616,925 · Granted Aug 1, 2006

Implantable article for treatment of urinary incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,083,568
App. No.
10/616,925
Granted
Aug 1, 2006
Kind
B2
Abstract

An implantable article and method of use are disclosed to treat urological disorders. The biocompatible device includes a sling assembly configured to be minimally invasive and provide sufficient support to the target site. In addition, the configuration of the sling assembly also allows the position of the sling to be permanently changed during and/or after implantation.

Claims (34)

1. A sling for treating urinary incontinence in a patient comprising:

first and second major surfaces,

a pair of end portions,

a support portion for placement in a therapeutically effective position relative to a physiological environment intended to be supported, the support portion having an axially elongate mesh, and a pair of ends, and

repositioning means, associated with the sling, for transferring sling tightening or sling loosening forces along the sling to afford effective, permanent repositioning of the sling without adversely affecting the therapeutic effect of the sling, said repositioning means being manually adjustable to control said sling tightening and loosening forces.

2. A sling according to claim 1 wherein the sling is constructed for treating female incontinence with a surgical procedure that includes a vaginal incision, and the repositioning means is without any structure that extends through the vaginal incision.

3. A sling according to claim 1 wherein the sling is initially placed via an access incision such as a vaginal incision, and the repositioning means affords post operative loosening of the sling after the vaginal incision is closed without any subsequent vaginal incision and without any structure extending through the original vaginal incision.

4. A sling according to claim 1 wherein the repositioning means transfers sling tightening or sling loosening forces along the sling while avoiding permanent deformation of the sling.

5. A sling according to claim 1 , wherein the repositioning means comprises at least one filament threaded along the mesh.

6. A sling according to claim 5 , wherein the filament is attached to the mesh at the ends of the support portion.

7. A sling according to claim 1 , wherein the repositioning means comprises at least one filament integrally woven in the mesh.

8. A sling according to claim 1 , wherein the mesh has a length, and the repositioning means comprises a plurality of filaments that are each threaded along substantially the entire length of the mesh.

9. A sling according to claim 8 wherein the filaments extend from an edge of the support portion to the other edge of the support portion.

10. A sling according to claim 1 , wherein the mesh of the support portion is woven and the repositioning means comprises a portion of the support portion that is more tightly woven than another portion of the support portion.

11. A sling according to claim 1 , wherein the sling comprises a woven mesh and the repositioning means comprises a portion of the mesh that is more tightly woven than another portion of the sling.

12. A sling according to claim 1 , wherein the repositioning means is constructed to afford transfer at least some of a repositioning force applied to the sling to an end of the support portion.

13. A sling according to claim 1 wherein the sling includes synthetic material.

14. A sling according to claim 1 , wherein the repositioning member includes a coating selected from the group consisting of medicaments, hormones, antibiotics, antimicrobials, dyes, silicone elastomers, polyurethanes, radiopaque substances, anti-bacterial substances, and combinations thereof.

15. A sling according to claim 1 wherein the sling includes a coating selected from the group consisting of medicaments, hormones, antibiotics, antimicrobials, dyes, silicone elastomers, polyurethanes, radiopaque substances, anti-bacterial substances, and combinations thereof.

16. A sling according to claim 1 wherein at least a portion of the sling is constructed from a bioabsorable material constructed to retain predetermined properties after implantation for at least a predetermined amount of time.

17. A sling according to claim 1 wherein at least a portion of the repositioning member is a resorbable material constructed to retain predetermined properties after implantation for at least a predetermined amount of time.

18. A sling according to claim 1 wherein the repositioning member is woven in a weave pattern along the mesh so that the weave pattern affords an indication of proper sling orientation after implantation.

19. A sling according to claim 18 wherein a majority of the repositioning member protrudes above the second major side of the support portion of the sling.

20. A sling according to claim 1 further including a sheath.

21. A sling according to claim 20 wherein the sheath indicia means for assisting the surgeon is properly orienting the sling relative to the urethra.

22. A sling according to claim 21 wherein the sheath includes separation means selected from the group consisting of tear scores, perforations or holes.

23. A sling according to claim 20 wherein the sheath comprises first and second sections that overlap adjacent the support portion of the sling.

24. A sling according to claim 1 wherein the sling and repositioning means are of contrasting colors and each of the sling and the repositioning means are of a color that contrasts with the physiological environment it will be implanted to assist a surgeon in identifying and distinguishing between the sling, the repositioning means and the physiological environment.

25. A sling according to claim 1 wherein the sling mesh is braided.

26. A sling according to claim 1 wherein the sling mesh is knitted.

27. A sling according to claim 1 wherein the sling has a length, the repositioning means comprises a one piece, elongate member threaded in the mesh and extending axially along substantially the entire length of the sling, and wherein the one piece, elongate member is attached to the sling at the ends of the support portion.

28. A sling according to claim 27 wherein the sling includes a means for locating and detaching the one piece, elongate member.

29. A sling according to claim 28 wherein the means for locating and detaching the one piece, elongate member comprises loops in the elongate, one piece member at the ends of the support portion.

30. A sling according to claim 1 wherein the repositioning means comprises a handle situated in the support portion.

Assignments (18)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0318. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Sep 6, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 039919/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0260 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0354 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0318 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 032379/0501 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2011
From: AMERICAN MEDICAL SYSTEMS, INC.
To: AMS RESEARCH CORPORATION
Reel/Frame 027117/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2011
From: NEISZ, JOHANN J.; WESTRUM, JOHN W., JR.; PORTER, CHRISTOPHER H.
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 027115/0479 →
SECURITY AGREEMENT Recorded Jul 21, 2011
From: AMERICAN MEDICAL SYSTEMS, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026628/0260 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2011
From: CIT HEALTHCARE LLC
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 026142/0569 →
SECURITY AGREEMENT Recorded Aug 18, 2006
From: AMERICAN MEDICAL SYSTEMS, INC.
To: CIT HEALTHCARE LLC
Reel/Frame 018132/0639 →